Merck KGaA (MRK) PT Set at €105.00 by Goldman Sachs Group, Inc. (The)
Goldman Sachs Group, Inc. (The) set a €105.00 ($125.00) price objective on Merck KGaA (FRA:MRK) in a report released on Tuesday morning. The brokerage currently has a neutral rating on the healthcare company’s stock.
Other analysts have also issued research reports about the company. Warburg Research set a €116.00 ($138.10) target price on Merck KGaA and gave the company a neutral rating in a report on Tuesday, June 20th. equinet AG set a €112.00 ($133.33) target price on Merck KGaA and gave the company a neutral rating in a report on Monday, June 26th. J P Morgan Chase & Co restated a neutral rating on shares of Merck KGaA in a report on Friday, August 4th. Deutsche Bank AG set a €106.00 ($126.19) target price on Merck KGaA and gave the company a neutral rating in a report on Friday, August 4th. Finally, Kepler Capital Markets set a €128.00 ($152.38) target price on Merck KGaA and gave the company a buy rating in a report on Thursday, June 1st. Thirteen analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Merck KGaA presently has an average rating of Hold and an average target price of €108.38 ($129.02).
Shares of Merck KGaA (FRA MRK) opened at 96.51 on Tuesday. The stock has a market cap of €41.96 billion and a P/E ratio of 25.16. The stock has a 50 day moving average price of €93.46 and a 200-day moving average price of €102.32. Merck KGaA has a 12 month low of €89.00 and a 12 month high of €115.00.
About Merck KGaA
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.